MDEV
First Trust Indxx Medical Devices ETF
MDEV tracks an equal-weighted index that gives global exposure to the medical equipment industry.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
2.0 M
ASSETS UNDER MGMT
70 bp
EXPENSES
Fund Basics
| Fund sponsor | First Trust |
| Category | Global |
| Asset class | Equity |
| Website | link... |
| Inception date | Jun 22, 2021 |
| Assets (mns) | $2 |
| Expense ratio | 70 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Quarterly |
| Taxation | 1099 |
| Stock selection | Market Cap |
| Weighting | Equal |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SARTORIUS STEDIM BIOTECH SA | 2.4 % |
| HOYA CORP | 2.2 % |
| CARL ZEISS MEDITEC AG | 2.1 % |
| ALIGN TECHNOLOGY INC | 2.1 % |
| ALCON, INC. | 2.1 % |
| PHILIPS ELECTRONICS NV | 2.1 % |
| COOPER COS INC/THE | 2.1 % |
| ABBOTT LABORATORIES | 2.1 % |
| BIOMERIEUX SA | 2.1 % |
| SMITH & NEPHEW PLC | 2.1 % |
Constituent Breakdown
| Number of holdings | 54 |
| Herfindahl-Hirschman Index | 210 |
| Wgt avg mkt cap (mns) | $43,516 |
| Large cap (>$10bn) | 82.9% |
| Mid cap ($2-10bn) | 17.1% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 97.9% |
| Emerging mkts. | 2.1% |
Country Exposure
 |
UNITED STATES | 57.3 % |
 |
JAPAN | 8.0 % |
 |
SWITZERLAND | 6.1 % |
 |
FRANCE | 4.4 % |
 |
GERMANY | 4.1 % |
 |
DENMARK | 4.0 % |
 |
IRELAND | 4.0 % |
 |
NETHERLANDS | 2.1 % |
 |
BRITAIN | 2.1 % |
 |
AUSTRALIA | 2.0 % |
Historical Performance
Standardized Performance (as of 04/30/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -2.7% | -0.2% | -2.6% | 0.5% | -- | -- | -- | -5.9% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | -2.7% | -0.2% | -2.6% | 0.5% | -- | -- | -- | -5.9% | Ann. Volatility | 24.4% | 17.3% | 16.3% | 19.8% | -- | -- | -- | 19.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.08 | 71% |
| MSCI EAFE | 1.12 | 80% |
| MSCI Emg Mkts | 0.85 | 47% |
Liquidity Measures
| Avg. volume (000) | 0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.31% |
| ADV of underlying (mns) | $5,549 |
Technical Indicators
| Recent close | $20.00 |
| 30d moving avg. | $19.58 |
| Annualized volatility | 21.1% |
| Relative strength (RSI) | 49 |
| Short interest (ETF) | 0.0% |
| Short interest (underlying) | 0.0% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MDEV |
Expenses vs. MDEV |
ALTAR Score™ vs. MDEV |
|---|---|---|---|---|
| XHE | SPDR S&P Health Care Equipment ETF | 39.8% | -35 bp | -1.2% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 39.8% | -30 bp | +3.4% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 36.9% | -2 bp | -1.9% |
| IHI | iShares U.S. Medical Devices ETF | 33.1% | -30 bp | -0.4% |
| BMED | Future Health ETF | 26.5% | +15 bp | -3.7% |
| FXH | First Trust Health Care AlphaDEX Fund | 26.4% | -8 bp | +4.7% |
| FMED | Fidelity Disruptive Medicine ETF | 26.2% | -20 bp | -5.4% |
| AGNG | Global X Aging Population ETF | 24.5% | -20 bp | +0.5% |
| IYH | iShares U.S. Healthcare ETF | 22.1% | -30 bp | +2.4% |
| IXJ | iShares Global Healthcare ETF | 22.1% | -28 bp | +2.5% |
Risk and Returns: MDEV vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2024 | 2025 | 2026 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/30/2025
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
MDEV
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
UNDERWEIGHT
Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.
ALTAR Score™
MDEV
4.2%
Cat. Avg
5.2%
ALTAR Score™ Calculation
Category Overview
There are 360 funds in the Global Equity category, with an average ALTAR Score™
of 5.2% and a standard deviation of
3.5%. MDEV's ALTAR Score™ is approximately
0.3 standard deviations
below
the category average. This places MDEV in the 39th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
MDEVSELL
U/W
HOLD
O/W
BUY
Expense Analysis
| Peer Group | Rules-Based Global Equity ETFs |
| # of ETFs | 191 |
| Avg. Expense Ratio | 55.4 bp |
| Std. Deviation | 17.5 bp |
| MDEV (70 bp) Percentile rank | 80 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
| Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
|---|---|---|---|
| MDEV | 70.0 | 31.3 | 101.3 |
| Peer Avg. | 55.2 | 32.9 | 88.1 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .